ERBB2 and neoplasm: MicroRNA can also be used to classify a specific tumor phenotype, such as in breast cancer, where it has been possible to connect the miRNA profile with the estrogen and progesterone receptor status, proliferation and tumor stage [87,88], and even define the molecular subtype (luminal A, luminal B, basal-like, HER2 and normal-like) [89].